Obalon_Logo_Teal_2c.jpg
Obalon Announces First Quarter 2017 Financial Results
10 mai 2017 08h01 HE | Obalon Therapeutics, Inc.
SAN DIEGO, May 10, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon_Logo_Teal_2c.jpg
Obalon Announces First Quarter 2017 Financial Results Conference Call
05 mai 2017 09h02 HE | Obalon Therapeutics, Inc.
SAN DIEGO, May 05, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon_Logo_Teal_2c.jpg
Obalon Balloon System to be Included in Two Presentations at the Aesthetic Meeting 2017
28 avr. 2017 17h31 HE | Obalon Therapeutics, Inc.
SAN DIEGO, April 28, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon_Logo_Teal_2c.jpg
David Moatazedi Joins Obalon Therapeutics, Inc. Board of Directors
15 mars 2017 16h31 HE | Obalon Therapeutics, Inc.
SAN DIEGO, March 15, 2017 (GLOBE NEWSWIRE) --  Obalon Therapeutics Inc. (NASDAQ:OBLN), a vertically integrated medical technology company, announced today that David Moatazedi, Senior Vice...
Obalon_Logo_Teal_2c.jpg
Obalon Therapeutics, Inc. Announces Fourth Quarter and Full Year 2016 Financial Results
23 févr. 2017 07h45 HE | Obalon Therapeutics, Inc.
SAN DIEGO, Feb. 23, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon_Logo_Teal_2c.jpg
Obalon Therapeutics, Inc. Announces Fourth Quarter and Year End 2016 Financial Results Conference Call
15 févr. 2017 08h43 HE | Obalon Therapeutics, Inc.
SAN DIEGO, Feb. 15, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon_Logo_Teal_2c.jpg
Obalon Therapeutics, Inc. to Ring The Nasdaq Stock Market Closing Bell
19 janv. 2017 08h18 HE | Obalon Therapeutics, Inc.
SAN DIEGO, Jan. 19, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics Inc. (NASDAQ:OBLN), a vertically integrated medical technology company, announced today that they will be ringing the Nasdaq Stock...
Obalon_Logo_Teal_2c.jpg
Jonah Shacknai Joins Obalon Therapeutics, Inc. Board of Directors
17 janv. 2017 08h27 HE | Obalon Therapeutics, Inc.
SAN DIEGO, Jan. 17, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics Inc. (NASDAQ:OBLN), a vertically integrated medical technology company, announced today that Jonah Shacknai, Executive Chairman of...
Obalon_Logo_Teal_2c.jpg
Obalon Announces Initial Commercial Patient Placements of the First and Only Swallowable, FDA-Approved Balloon System for Weight Loss
13 janv. 2017 08h02 HE | Obalon Therapeutics, Inc.
SAN DIEGO, Calif., Jan. 13, 2017 (GLOBE NEWSWIRE) -- Obalon Therapeutics Inc. (NASDAQ:OBLN), a vertically integrated medical technology company, announced that it has begun U.S. commercial shipments...
Obalon Therapeutics To Present at Two Upcoming Investor Conferences
14 nov. 2016 07h24 HE | Obalon Therapeutics, Inc.
SAN DIEGO, Nov. 14, 2016 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable,...